Xiangzheng Su

Xiangzheng Su

Auto-generated profile, based on publicly available information

Xiangzheng Su

A Department of Sport Medical , Chinese PLA General hospital , Beijing , China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2017 in Arthroscopy
Verified
Journal Article
Closed access
XSXiangzheng Su
Xiangzheng Su
CLChunbao Li
Chunbao Li
WLWeixiong Liao
Weixiong Liao
JLJianheng Liu
Jianheng Liu
HZHao Zhang
Hao Zhang
ZLZhongli Li
Zhongli Li

20 June 2017 in Chinese Medical Journal
Verified
Journal Article
Open access
JLJI LI
JI LI
LZLi Zhongli
Li Zhongli
HZHao Zhang
Hao Zhang
XSXiang-Zheng Su
Xiang-Zheng Su
KWKe-Tao Wang
Ke-Tao Wang
YYYi-Meng Yang
Yi-Meng Yang
Iple small-diameter drilling decompression combined with hip arthroscopy for early AVNFH compared to drilling alone. Methods: This is a nonrandomized retrospective case series study. Between April 2006 and November 2010, 60 patients (98 hips) with early stage AVNFH participated in this study. The patients underwent multiple small-diameter drilling decompression combined with hip arthroscopy in 26 cases/43 hips (Group A) or drilling decompression alone in 34 cases/55 hips (Group B). Patients were followed up at 6, 12, and 24 weeks, and every 6 months thereafter. Radiographs were taken at every follow-up, Harris scores were recorded at the last follow-up, the paired t-test was used to compare the postoperative Harris scores. Surgery effective rate of the two groups was compared using the Chi-square test. Results: All patients were followed up for an average of 57.6 months (range: 17–108 months). Pain relief and improvement of hip function were assessed in all patients at 6 months after the surgery. At the last follow-up, Group A had better outcome with mean Harris’ scores improved from 68.23 ± 11.37 to 82.07 ± 2.92 (t = −7.21, P = 0.001) than Group B with mean Harris’ scores improved from 69.46 ± 9.71 to 75.79 ± 4.13 (t = –9.47, P = 0.037) (significantly different: t = –2.54, P = 0.017). The total surgery effective rate was also significantly different between Groups A and B (86.0% vs. 74.5%; χ2 = 3.69, P = 0.02). Conclusion: For early stage of AVNFH, multiple small-diameter drilling decompression combined with hip arthroscopy is more effective than drilling decompression alone....

9 June 2017 in Disability and Rehabilitation
Verified
Journal Article
Closed access
XSXiangzheng Su
Xiangzheng Su
ZLZhongli Li
Zhongli Li
ZLZhengsheng Liu
Zhengsheng Liu
TSTeng Shi
Teng Shi
CXChao Xue
Chao Xue
Purpose: The aim of this study was to investigate the efficacy of high- and low-energy radial shock waves combined with physiotherapy for rotator cuff tendinopathy patients. Methods: Data from rotator cuff tendinopathy patients received high- or low-energy radial shock waves combined with physiotherapy or physiotherapy alone were collected. The Constant and Murley score and visual analog scale score were collected to assess the effectiveness of treatment in three groups at 4, 8, 12, and 24 weeks. Results: In total, 94 patients were involved for our retrospective study. All groups showed remarkable improvement in the visual analog scale and Constant and Murley score compared to baseline at 24 weeks. The high-energy radial shock waves group had more marked improvement in the Constant and Murley score compared to the physiotherapy group at 4 and 8 weeks and at 4 weeks when compared with low-energy group. Furthermore, high-energy radial shock waves group had superior results on the visual analog scale at 4, 8, and 12 weeks compared to low-energy and physiotherapy groups. Conclusions: This retrospective study supported the usage of high-energy radial shock waves as a supplementary therapy over physiotherapy alone for rotator cuff tendinopathy by relieving the symptoms rapidly and maintaining symptoms at a satisfactory level for 24 weeks.

2 May 2023 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
LSLi Song
Li Song
XSXiangzheng Su
Xiangzheng Su
YLYao Lu
Yao Lu
DHDongliang Hua
Dongliang Hua
LSLi Song
Li Song
Hepatocellular carcinoma (HCC) is a typical inflammation-driven cancer and ranks sixth in the incidence rate worldwide. The role of adenylate uridylate- (AU-) rich element genes (AREGs) in HCC remains unclear. HCC-related datasets were acquired from The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) database. Differentially expressed AREGs (DE-AREGs) between HCC samples and healthy controls were identified. The univariate Cox and LASSO analyses were performed to determine the prognostic genes. Furthermore, a signature and corresponding nomogram were configured for the clinical prediction of HCC. The potential signature-related biological significance was explored using functional and pathway enrichment analysis. Additionally, immune infiltration analysis was also performed. Finally, the expression of prognostic genes was verified using real-time quantitative polymerase chain reaction (RT-qPCR). A total of 189 DE-AREGs between normal and HCC samples were identified, wherein CENPA, TXNRD1, RABIF, UGT2B15, and SERPINE1 were selected to generate an AREG-related signature. Moreover, the prognostic accuracy of the AREG-related signature was also confirmed. Functional analysis indicated that the high-risk score was related to various functions and pathways. Inflammation and immune-related analyses indicated that the difference of T cell and B cell receptor abundance, microvascular endothelial cells (MVE), lymphatic endothelial cells (lye), pericytes, stromal cells, and the six immune checkpoints was statistically significant between the different risk groups. Similarly, RT-qPCR outcomes of these signature genes were also significant. In conclusion, an inflammation-associated signature based on five DE-AREGs was constructed, which could act as a prognostic indicator of patients with HCC.

22 May 2026 in Chinese Journal of Traumatology
Verified
Journal Article
Open access
XSXiangzheng Su
Xiangzheng Su
WSWei Sheng
Wei Sheng
JCJing Chen
Jing Chen
QLQiankun Li
Qiankun Li
QXQin Xu
Qin Xu
YJYufeng Jiang
Yufeng Jiang
Diabetic foot osteomyelitis (DFO) presents substantial therapeutic challenges due to refractory healing and high recurrence rates. While platelet-rich plasma (PRP) demonstrates wound-healing potential, its efficacy in DFO management requires further exploring. This study aimed to evaluate the clinical efficacy of PRP in DFO management. This is a retrospective cohort study compared surgical outcomes between DFO patients receiving conventional therapy (n = 63) vs. PRP-augmented treatment (n = 68) during January 2020 and January 2025. Primary endpoints included wound healing rates (quantified at 7, 14, 30, and 90 days) and hospitalization parameters including duration of hospitalization, treatment costs, and microbial profiles. Secondary analysis evaluated Wagner grade 4 subpopulations. Baseline characteristics were analyzed using descriptive statistics. The wound healing rate at each time points between PRP and control group was compared by the analysis of covariance RESULTS: PRP administration resulted in a significantly higher 7-day wound closure rate compared to the control group (88.10% ± 10.37% vs. 83.51% ± 10.85%, p = 0.015). In patients with Wagner grade 3, the PRP group exhibited a significantly greater healing rate at 7 days (98.64% ± 2.40% vs. 94.95% ± 5.19%, p = 0.018) while no statistical difference was found at other time points (14 days: 99.71% ± 0.73% vs. 98.86% ± 2.24%, p = 0.193; 30 days 99.83% ± 0.58% vs. 98.00% ± 7.28%, p = 0.386; 90 days 99.67% ± 1.15% vs. 99.36% ± 1.89%, p = 0.626). Moreover, among those with Wagner grade 4, the PRP group demonstrated consistently superior healing outcomes across all time points (7 days: 89.94% ± 8.35% vs. 78.33% ± 12.20%, p = 0.006; 90 days: 99.93% ± 0.37% vs. 98.33% ± 4.08%, p = 0.008). Treatment with PRP was also associated with a 13.3% reduction in the mean hospitalization duration ((28.47 ± 10.43) days vs. (32.85 ± 11.50) days, p = 0.029), despite incurring higher treatment costs ($6740.44 ± $3048.42 vs. $5370.97 ± $3600.43, p = 0.025). No adverse events related to PRP application were observed. The present study demonstrates that PRP significantly accelerated the wound healing process in DFO patients, especially in Wagner grade 3 and 4 cases. Despite the associated increase in cost, PRP treatment led to a marked reduction in hospital stay. These findings suggest that PRP may constitute a promising therapeutic strategy for DFO management, offering improved clinical outcomes while maintaining an acceptable safety profile.